Microbot Medical (MBOT) Competitors $2.88 +0.23 (+8.68%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$2.82 -0.06 (-2.26%) As of 06:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBOT vs. DCTH, TMCI, OM, SNWV, RXST, CLPT, CATX, NNOX, STIM, and NPCEShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Outset Medical (OM), Sanuwave Health (SNWV), RxSight (RXST), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), Nano-X Imaging (NNOX), Neuronetics (STIM), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Its Competitors Delcath Systems Treace Medical Concepts Outset Medical Sanuwave Health RxSight ClearPoint Neuro Perspective Therapeutics Nano-X Imaging Neuronetics NeuroPace Delcath Systems (NASDAQ:DCTH) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership. Do institutionals and insiders have more ownership in DCTH or MBOT? 61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 17.9% of Delcath Systems shares are held by insiders. Comparatively, 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is DCTH or MBOT more profitable? Microbot Medical has a net margin of 0.00% compared to Delcath Systems' net margin of -26.38%. Delcath Systems' return on equity of -29.44% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems-26.38% -29.44% -20.75% Microbot Medical N/A -110.27%-94.20% Which has more risk and volatility, DCTH or MBOT? Delcath Systems has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Does the media refer more to DCTH or MBOT? In the previous week, Microbot Medical had 3 more articles in the media than Delcath Systems. MarketBeat recorded 6 mentions for Microbot Medical and 3 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.58 beat Microbot Medical's score of 0.40 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Microbot Medical 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, DCTH or MBOT? Microbot Medical has lower revenue, but higher earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$37.21M9.85-$26.39M-$0.50-21.04Microbot MedicalN/AN/A-$11.44M-$0.65-4.43 Do analysts prefer DCTH or MBOT? Delcath Systems presently has a consensus target price of $24.00, suggesting a potential upside of 128.14%. Microbot Medical has a consensus target price of $9.00, suggesting a potential upside of 212.50%. Given Microbot Medical's higher possible upside, analysts clearly believe Microbot Medical is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryDelcath Systems beats Microbot Medical on 8 of the 14 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$96.40M$7.01B$5.59B$9.53BDividend YieldN/A1.23%4.71%4.14%P/E Ratio-4.4320.9628.8923.88Price / SalesN/A58.49447.6498.82Price / CashN/A21.0735.6858.35Price / Book16.945.608.165.60Net Income-$11.44M$178.18M$3.25B$265.26M7 Day Performance11.20%-1.52%1.12%-0.15%1 Month Performance10.77%-3.19%8.22%6.07%1 Year Performance200.56%12.09%29.12%24.21% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical1.6795 of 5 stars$2.88+8.7%$9.00+212.5%+225.6%$96.40MN/A-4.4320News CoverageUpcoming EarningsGap UpDCTHDelcath Systems2.8545 of 5 stars$11.41flat$24.00+110.3%+26.4%$397.37M$37.21M0.0060TMCITreace Medical Concepts2.3681 of 5 stars$5.75+0.9%$10.52+82.9%-11.7%$358.47M$209.36M0.00250News CoveragePositive NewsUpcoming EarningsOMOutset Medical1.744 of 5 stars$18.04-2.6%$29.50+63.5%-73.1%$328.39M$113.69M-0.62520News CoveragePositive NewsSNWVSanuwave Health2.2728 of 5 stars$35.75-5.6%N/AN/A$324.43M$32.63M0.0040Gap UpRXSTRxSight3.2937 of 5 stars$7.87-1.3%$17.50+122.4%-81.2%$323.88M$139.93M0.00220Trending NewsUpcoming EarningsCLPTClearPoint Neuro2.8195 of 5 stars$10.97-2.3%$25.00+127.9%+62.5%$314.32M$31.39M0.00110Upcoming EarningsCATXPerspective Therapeutics2.5857 of 5 stars$4.12+1.5%$12.56+204.7%-67.2%$305.82MN/A0.0070Upcoming EarningsNNOXNano-X Imaging1.9611 of 5 stars$5.14-1.2%$9.50+84.8%-32.4%$300.45M$11.28M0.00190News CoverageUpcoming EarningsGap UpSTIMNeuronetics1.1903 of 5 stars$4.52+0.7%$5.50+21.7%+155.6%$296.85M$74.89M0.00180News CoverageGap DownNPCENeuroPace3.245 of 5 stars$8.74-2.7%$17.00+94.5%+25.0%$294.53M$79.91M0.00170News CoverageUpcoming Earnings Related Companies and Tools Related Companies Delcath Systems Alternatives Treace Medical Concepts Alternatives Outset Medical Alternatives Sanuwave Health Alternatives RxSight Alternatives ClearPoint Neuro Alternatives Perspective Therapeutics Alternatives Nano-X Imaging Alternatives Neuronetics Alternatives NeuroPace Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBOT) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBOT Stock Alerts